Vivimed Labs to acquire Finoso Pharma for Rs 15 crore

15 Feb 2013 Evaluate

Vivimed Labs has proposed to acquire Finoso Pharma for a total consideration of Rs 15 crore comprising cash, stock and deferred payment. Post acquisition, Finoso will become Vivimed’s research and development (R&D) unit to support innovators, generics and licensing efforts.

Finoso Pharma is a pharmaceutical development services company focused on formulations product development efforts for multiple markets and develops globally accepted dossiers.

Vivimed Labs Share Price

16.75 -0.88 (-4.99%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×